ORYZF
Price
$3.61
Change
+$0.23 (+6.80%)
Updated
Oct 3 closing price
Capitalization
299.09M
Intraday BUY SELL Signals
PPBT
Price
$0.60
Change
+$0.01 (+1.69%)
Updated
Feb 4, 04:57 PM (EDT)
Capitalization
5.82M
Intraday BUY SELL Signals
Interact to see
Advertisement

ORYZF vs PPBT

Header iconORYZF vs PPBT Comparison
Open Charts ORYZF vs PPBTBanner chart's image
Oryzon Genomics SA
Price$3.61
Change+$0.23 (+6.80%)
Volume$1K
Capitalization299.09M
Purple Biotech
Price$0.60
Change+$0.01 (+1.69%)
Volume$580
Capitalization5.82M
ORYZF vs PPBT Comparison Chart in %
ORYZF
Daily Signal:
Gain/Loss:
PPBT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ORYZF vs. PPBT commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORYZF is a Hold and PPBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ORYZF: $3.60 vs. PPBT: $0.59)
Brand notoriety: ORYZF and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORYZF: 602% vs. PPBT: 12%
Market capitalization -- ORYZF: $299.09M vs. PPBT: $5.82M
ORYZF [@Biotechnology] is valued at $299.09M. PPBT’s [@Biotechnology] market capitalization is $5.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORYZF’s FA Score shows that 1 FA rating(s) are green whilePPBT’s FA Score has 1 green FA rating(s).

  • ORYZF’s FA Score: 1 green, 4 red.
  • PPBT’s FA Score: 1 green, 4 red.
According to our system of comparison, ORYZF is a better buy in the long-term than PPBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORYZF’s TA Score shows that 2 TA indicator(s) are bullish while PPBT’s TA Score has 4 bullish TA indicator(s).

  • ORYZF’s TA Score: 2 bullish, 2 bearish.
  • PPBT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ORYZF and PPBT are a good buy in the short-term.

Price Growth

ORYZF (@Biotechnology) experienced а 0.00% price change this week, while PPBT (@Biotechnology) price change was -7.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORYZF($299M) has a higher market cap than PPBT($5.82M). ORYZF YTD gains are higher at: 7.143 vs. PPBT (-10.403). PPBT has higher annual earnings (EBITDA): -3.57M vs. ORYZF (-7.91M). ORYZF has more cash in the bank: 40.4M vs. PPBT (10.5M). PPBT has less debt than ORYZF: PPBT (256K) vs ORYZF (13.7M). ORYZF (0) and PPBT (0) have equivalent revenues.
ORYZFPPBTORYZF / PPBT
Capitalization299M5.82M5,135%
EBITDA-7.91M-3.57M222%
Gain YTD7.143-10.403-69%
P/E RatioN/A0.00-
Revenue00-
Total Cash40.4M10.5M385%
Total Debt13.7M256K5,352%
FUNDAMENTALS RATINGS
PPBT: Fundamental Ratings
PPBT
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORYZFPPBT
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
18%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
21%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
18%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ORYZF
Daily Signal:
Gain/Loss:
PPBT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOP30.310.62
+2.09%
Koppers Holdings
YUMC50.740.16
+0.32%
Yum China Holdings
DBRG15.450.01
+0.06%
DigitalBridge Group
MX2.87-0.03
-1.03%
Magnachip Semiconductor Corp
CANF4.05-0.08
-1.94%
Can-Fite Biopharma Ltd

ORYZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORYZF has been loosely correlated with CLDI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORYZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORYZF
1D Price
Change %
ORYZF100%
N/A
CLDI - ORYZF
37%
Loosely correlated
-0.44%
PPBT - ORYZF
28%
Poorly correlated
-2.79%
DRUG - ORYZF
25%
Poorly correlated
-3.12%
GNNSF - ORYZF
24%
Poorly correlated
N/A
IPSC - ORYZF
20%
Poorly correlated
N/A
More

PPBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PPBT has been loosely correlated with SNTI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PPBT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPBT
1D Price
Change %
PPBT100%
-2.79%
SNTI - PPBT
58%
Loosely correlated
-2.97%
BCYC - PPBT
32%
Poorly correlated
-7.55%
ARTL - PPBT
32%
Poorly correlated
-6.13%
APLM - PPBT
31%
Poorly correlated
-10.24%
ORYZF - PPBT
29%
Poorly correlated
N/A
More